Citation: Kr. Brader et al., EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) ANTISENSE TRANSFECTION REDUCES THE EXPRESSION OF EGFR AND SUPPRESSES THE MALIGNANT PHENOTYPE OF A HUMAN OVARIAN-CANCER CELL-LINE, Oncology Reports, 5(5), 1998, pp. 1269-1274
Authors:
BRADER KR
MORRIS M
LEVENBACK C
LEVY L
LUCAS KR
GERSHENSON DM
Citation: Kr. Brader et al., CHEMOTHERAPY FOR CERVICAL-CARCINOMA - FACTORS DETERMINING RESPONSE AND IMPLICATIONS FOR CLINICAL-TRIAL DESIGN, Journal of clinical oncology, 16(5), 1998, pp. 1879-1884
Authors:
MORRIS M
BRADER KR
LEVENBACK C
BURKE TW
ATKINSON EN
SCOTT WR
GERSHENSON DM
Citation: M. Morris et al., PHASE-II STUDY OF VINORELBINE IN ADVANCED AND RECURRENT SQUAMOUS-CELLCARCINOMA OF THE CERVIX, Journal of clinical oncology, 16(3), 1998, pp. 1094-1098
Citation: M. Morris et al., PHASE-II STUDY OF PROLONGED ORAL ETOPOSIDE IN ADVANCED OR RECURRENT CARCINOMA OF THE CERVIX, Gynecologic oncology (Print), 70(2), 1998, pp. 215-218
Authors:
MANGURTEN AB
BRADER KR
LOOS BM
LEE E
QUIROGA AI
BATHORI J
LURAIN JR
LASZLO A
PHILLIPS B
Citation: Ab. Mangurten et al., HSP70 AND HSC70 ARE PREFERENTIALLY EXPRESSED IN DIFFERENTIATED EPITHELIAL-CELLS IN NORMAL HUMAN ENDOMETRIUM AND ECTOCERVIX, Cell stress & chaperones, 2(3), 1997, pp. 168-174
Authors:
BRADER KR
WOLF JK
HUNG MC
YU DH
CRISPENS MA
VANGOLEN KL
PRICE JE
Citation: Kr. Brader et al., ADENOVIRUS E1A EXPRESSION ENHANCES THE SENSITIVITY OF AN OVARIAN-CANCER CELL-LINE TO MULTIPLE CYTOTOXIC AGENTS THROUGH AN APOPTOTIC MECHANISM, Clinical cancer research, 3(11), 1997, pp. 2017-2024